aTYR PHARMA INC Operating Leases, Future Minimum Payments, Due in Three Years
aTYR PHARMA INC (ATYR) had Operating Leases, Future Minimum Payments, Due in Three Years of $1.03 million as of 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-03-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Three Years $1.03M.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $1.00M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Three Years $420.00K.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Three Years $420.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Three Years |
|---|---|
| 2018-12-31 | $1.03M 10-K · filed 2019-03-26 |
| 2018-09-30 | $1.00M 10-Q · filed 2018-11-14 |
| 2017-09-30 | $420.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $420.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $293.00K 10-Q · filed 2017-05-11 |
| 2015-09-30 | $231.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $231.00K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $231.00K 10-Q · filed 2015-06-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |